Bereaved Parent Study

Bereavement Clinical Trial

Official title:

The Bereaved Parent Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02425787
• Other study ID #: BPS14
• Status: Completed
• Start date: March 1, 2016
• Est. completion date: August 21, 2020

Study information

• Verified date: October 2021
• Source: St. Jude Children's Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Recent focus groups at St. Jude Children's Research Hospital (SJCRH) revealed several limitations in our understanding of how parents' relationships with care staff help and hinder their grief experience. Additionally, there is a gap in the bereavement literature regarding the psychological effects professional caregiver relationships have on parents whose children died of cancer. To bolster our knowledge base and benefit Bereavement Care Services at SJCRH, as well as benefit other professionals by filling the gap in the literature, we have designed a qualitative study that will conduct individual interviews with bereaved parents whose children died at SJCRH.

Validation of the preliminary analyses of the initial 30 interviews will occur through new focus groups involving two separate sets of bereaved parents who will validate the findings and/or suggest additional avenues of inquiry needed to gain a more complete understanding of parental grief/bereavement experience. Additionally, focus groups with hematology/oncology fellows will obtain provider feedback on the value of these findings in their training and future role as physicians.

The initial focus group portion of this study is complete and more than 30 interviews have been conducted with bereaved parent participants. Review of those interviews revealed that very few parent participants had children who received bone marrow transplants. For this reason, we will now specifically be recruiting bereaved parent participants whose children received bone marrow transplants at St. Jude Children's Research Hospital. We will be recruiting parents of children who received haploidentical and non-haploidentical bone marrow transplants because we believe the parents of deceased children who received haploidentical bone marrow transplants may have unique bereavement experiences related to their possible roles as donors. The act of donating or not being selected to donate to a child who goes on to die from cancer and its related complications may have unique impacts on the grieving process and warrants specific investigation. We also hope to better understand how legacy building interventions are perceived and utilized by caregivers following the death of a child from cancer.

Description:

Participants who consent will engage with the principal investigator in a one-time voice-recorded interview consisting of demographic and open-ended questions. Participants can choose to conduct the interview face-to-face or over-the-phone. Completion of the interview is expected to take between 30-90 minutes. Validation focus groups are expected to take between 30-90 minutes, as well. For the legacy-building cohort, the Child Life Department will provide additional information to specify which bereaved families received legacy items, and parents will be recruited to participate in an interview centered on the legacy item questions.

PRIMARY OBJECTIVE

To conduct qualitative interviews in order to understand what helps and what hinders bereavement processes among St. Jude parents, with particular attention to how relationships with St. Jude professional care staff affect parental bereavement processes.

EXPLORATORY OBJECTIVES

To qualitatively explore the unique bereavement experiences and challenges of parents of children who have received bone marrow transplantation, and compare these experiences with those participants whose children did not receive bone marrow transplantation.

To assess for qualitative similarities among parents with similar responses on questionnaires and/or to identify between-group differences on questionnaires among parents with qualitatively similar experiences.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 66
• Est. completion date: August 21, 2020
• Est. primary completion date: August 21, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Must be at least 18 years of age.

• Must be English-speaking.

• Must have had a child who received oncological treatment at SJCRH.

• The child who received treatment must have died at least 1 year prior but no more than 6 years ago, with the cause of death related to progressive cancer or cancer-related complications.

OR

• English-speaking Hematology/oncology Fellows at SJCRH who are at least 17 years of age.

Exclusion Criteria:

• Potential participants who indicate active suicidal ideation with or without plans will be excluded from the study. Appropriate care and referral will be given as indicated.

Related Conditions & MeSH terms

• Bereavement

Intervention

Behavioral:
• Interview
This is a prospective study with a semi-structured in-depth qualitative interview. Interviews will be conducted by the study PI or designee. However, in order to ensure that the interviews are conducted sensitively, the first 10 interviews will be observed and supervised by a clinically credentialed St. Jude faculty member, and an additional 10% of the interviews will be observed after that. In order to ensure that the interviewer does not lead the participant, or in turn, that the participant does not feel limited in regards to what they believe is an appropriate or desired response, the semi-structured interview questions are general and intended to produce broad responses in regards to participant experiences.
• Focus Group
Focus groups will be conducted with a two-fold purpose in mind: With bereaved parents: to validate the findings of the preliminary analyses of the initial interviews &/or to suggest avenues of further inquiry to expand and more deeply define the grief journey of bereaved parents. With Hematology/Oncology Fellows: to receive input regarding the applicability and use of the findings during the training and future careers of these medical providers.
• Interview
The interview will be conducted by study team members and will center around legacy item-related questions.

Locations

Country	Name	City	State
United States	St. Jude Children's Research Hospital	Memphis	Tennessee

Sponsors (1)

Lead Sponsor	Collaborator
St. Jude Children's Research Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	To qualitatively explore the unique bereavement experiences and challenges of parents of children who received bone marrow transplantation, and compare these experiences with those participants whose children did not receive bone marrow transplantation.	We will use qualitative content analysis as described above to identify similarities and differences among the different cohorts of bereaved parents (parents whose children did not receive bone marrow transplantation, parents whose children received haploidentical bone marrow transplantation, and parents whose children received non-haploidentical bone marrow transplantation.	All data will be collected at the time of the initial interview.
Other	To assess for qualitative similarities among parents with similar responses on questionnaires and/or to identify between-group differences on questionnaires among parents with qualitatively similar experiences.	We will use the Beck Depression Inventory-II (BDI-II) to assess for symptoms of depression, the parental grief disorder questionnaire (PG-13) to assess for atypical or disordered grief, and the Integration of Stressful Life Experiences Scales (ISLES-SF) to measure the extent to which the child's loss has been integrated into the parent's worldview. We will identify different groups based on these questionnaires (ex: those with elevated scores on the BDI-II) and look to see if the thematic content of their interviews differs from other participants. Additionally, we may identify participants who expressed certain themes and assess for differences in their qualitative responses.	All data will be collected at the time of the initial interview.
Primary	Descriptive accounts of bereavement	Qualitative data will be collected using a standardized semi-structured interview technique. Researchers will analyze transcripts for content to gain a better understanding of the bereavement experience. Thematic saturation will occur when a minimum of 3 consecutive interviews fail to produce novel information in each of the therapeutic categories (haploidentical transplant, non-haploidentical transplant).Transcripts will be analyzed as they are obtained and the principal investigator and study team will iteratively and collaboratively develop a coding dictionary. Each transcript will be reviewed by at least 2 coders. When there is disagreement on a code, coders will meet in person to discuss until consensus is reached. Codes will be grouped into broader themes and used to summarize and describe the bereavement experience as told by parents.	Once, Day 0

External Links

•   Clinical Trials Open at St. Jude
•   St. Jude Children's Research Hospital